FDA cracks down on company marketing ‘ three-parent ’ babies

Is the Food and Drug Administration moving to assert more control over new technologies being used by the reproductive health industry? On Friday, regulators issued a sternly worded letter to fertility doctor John Zhang, who helped a mother with a genetic disorder give birth to a healthy baby boy by using a procedure that combines DNA from her, […]Related:FDA to step up targeting of fentanyl, other synthetic opioids at postal facilitiesFirst human embryo editing experiment in U.S. ‘corrects’ gene for heart conditionInsufficient sleep may add more than an inch to your waist, study suggests
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news